Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex von Ferres, H

Volltext

Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure speci... von Fears, R, Ferres, H, Glasgow, E, Standring, R, Hogg, K J, Gemmill, J D, Burns, J M A, Rae, A P, Dunn, F G, Hillis, W S

Volltext

Comparison of the effects of streptokinase, t-PA and APSAC on human platelet aggregation in vitro in the absence and presence of aspirin von Fears, R., Ferres, H., Greenwood, H.C.

Volltext

The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme—A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks von Fears, R., Richards, D.H., Ferres, H.

Volltext

Effects of novel bile salts on cholesterol metabolism in rats and guinea-pigs von Fears, R., Brown, R., Ferres, H., Grenier, F., Tyrrell, A.W.R.

Volltext

Kinetic studies on novel plasminogen activators. Demonstration of fibrin enhancement for hybrid enzymes comprising the A-chain of plasmin (Lys-78) and B-chain of tissue-type plasmi... von Fears, R, Dodd, I, Ferres, H, Robinson, J H

Volltext

Deacylation studies in vitro on anisoylated plasminogen streptokinase activator complex von Ferres, H, Hibbs, M, Smith, R A

Volltext

Clinical effects and kinetic properties of intravenous APSAC — anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction von Been, M., de Bono, D.P., Muir, A.L., Boulton, F.E., Fears, R., Standring, R., Ferres, H.

Volltext

A comparison of the pharmacokinetic properties of streptokinase and anistreplase in acute myocardial infarction von Gemmill, JD, Hogg, KJ, Burns, JM, Rae, AP, Dunn, FG, Fears, R., Ferres, H., Standring, R., Greenwood, H., Pierce, D., et al

Volltext

Pharmacokinetic properties of anisoylated plasminogen streptokinase activator complex and other thrombolytic agents in animals and in humans von Nunn, B, Esmail, A, Fears, R, Ferres, H, Standring, R

Volltext

The protective effect of acylation on the stability of anisoylated plasminogen streptokinase activator complex in human plasma von Fears, R, Ferres, H, Standring, R

Volltext

Consequences of antibody binding in vitro on the pharmacological properties of anisoylated plasminogen streptokinase activator complex von Fears, R, Ferres, H, Hibbs, M, Standring, R

Volltext

Evidence for the progressive uptake of anisoylated plasminogen streptokinase activator complex by clots in human plasma in vitro von Fears, R, Ferres, H, Standring, R

Volltext

Decrease in LDL and increase in HDL concentrations in type II hyperlipoproteinaemic patients on low-dose combination therapy of cholestyramine and Complamin von Fears, R., Ferres, H., Haacke, H., Mäder, C., Parwaresch, M.R.

Volltext

Hyperalphalipoproteinaemic activity of BRL 26314—II: Inhibition of atherosclerosis in rabbits von Fears, R., Esmail, A., Walker, P., Rush, W.R., Ferres, H.

Volltext

Preclinical, pharmacological evaluation of APSAC von Ferres, H.

Volltext

Effect of N‐desmethyldiazepam (nordiazepam) and a precursor, potassium clorazepate, on sleep in man von Nicholson, AN, Stone, BM, Clarke, CH, Ferres, HM

Volltext

BRL.8988 (Talampicillin), a Well-Absorbed Oral Form of Ampicillin von Clayton, J P, Cole, M, Elson, S W, Ferres, H

Volltext

Hyperalphalipoproteinaemic activity of BRL 26314—I: Enhanced cholesterol turnover in rats von Fears, R., Rush, W.R., Walker, P., Ferres, H.

Volltext

A diastereoselective synthesis of 4(RS), 6(SR)-mercaptomethylmevalonolactone, a key intermediate in the preparation of a new class of inhibitors of HMG-CoA reductase von Ferres, H., Hatton, I.K., Jennings, L.J.A., Tyrrell, A.W.R., Williams, D.J.

Volltext